At-Home Blood Collection Devices Market

The report "At-Home Blood Collection Devices Market by Product (Lancets, DBS Kits), Sample Type (Liquid, Dried), Collection Method (Push-button, Laser), Device Type (Self, Professional), Application (Diagnostics, Screening, Clinical Trials) - Global Forecast to 2029", is valued at an estimated USD 93 million in 2024 and is projected to reach USD 135 million by 2029 at a CAGR of 7.6% during the forecast period.

Browse 292 market data Tables and 42 Figures spread through 269 Pages and in-depth TOC on "At-Home Blood Collection Devices Market by Product (Lancets, DBS Kits), Sample Type (Liquid, Dried), Collection Method (Push-button, Laser), Device Type (Self, Professional), Application (Diagnostics, Screening, Clinical Trials) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/microsampling-devices-market-265517889.html

Several factors govern the growth of the at-home blood collection devices market. The rise in the need for convenient and easy access to health care, because of shifting trends toward personalized medicine and preventive medicine, acts as a major driver. The other key drivers are technological advancement, particularly in user-friendly and accurate collection devices, including microarray-based technologies and bladeless devices. Added to this, besides the regulatory approvals and increasing focus on patient-centric care, is the rising prevalence of chronic diseases, such as diabetes, that require regular monitoring. Also, the growing telemedicine and digital health platforms have made seamless integration of at-home based collection with virtual consults possible, thereby improving the overall patient experience and adding to the market expansion.

In 2023, the lancets segment held the largest share of the at-home blood collection devices market by product segment.

The segmentation of the market based on products includes lancets, dried blood spot collection kits, fingerstick blood collection kits, and other products. In 2023, the lancets segment dominated the at-home blood collection devices market. Lancets are cost-effective; hence, this offers a cheap method of monitoring conditions like diabetes regularly. This affordability makes them a more preferred choice by consumers, thereby holding a dominance in the market.

The liquid blood samples segment held the largest share of the at-home blood collection devices market by sample type segment in 2023.

The segmentation based on sample types includes liquid and dried blood samples. Liquid blood samples are used mostly for diagnostics and health screening. This is attributed to the fact that they have a reliable method of measuring different health markers. Therefore, technological advancements that enhance the accuracy of tests performed on these samples have increased their attractiveness to consumers.

North America is the largest regional market for at-home blood collection devices market.

The market for at-home blood collection devices has been divided into six key geographical regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. North America holds the largest share of the at-home blood collection devices market, owing to a well-established and infrastructurally sound healthcare systems and a large customer base for advanced medical technologies. Accordingly, this region also offers preventative health and personalized solutions allowing for better monitoring of a person's health.

This is further supported by the presence of leading manufacturers and a robust regulatory framework that makes sure the devices are safe and efficient. Furthermore, this region dominated the market due to the high spend on research and development in the healthcare sector, which facilitates easy traces of rapid developments in at-home blood collection devices.

The major players operating in this market are Trajan Group Holdings Limited (Australia), Tasso, Inc. (US), YourBio Health, Inc. (US), A. Menarini Diagnostics (UK), R-Biopharm AG (Germany), Sussex Pathology Limited (UK), ImmunoServ (UK), Labonovum (Netherlands), Alpha Laboratories (UK), Lipomic Healthcare (India), Tri-Tech Forensics (US), RDA Spot Inc (Lithuania), Spot On Sciences (US), Capitainer (Sweden), PanoHealth (US), Lameditech (South Korea), Sara Healthcare (India), Owen Mumford Ltd (UK), RedDrop Dx, Inc. (US), AdvaCare Pharma (US), Naulakha Industries (India), and Phoenix Healthcare Solutions, LLC (US).

Don’t miss out on business opportunities in At-Home Blood Collection Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]